BioNexus Gene Lab Corp. (BGLC) Financials

$0.35

north_east
$0.01 (2.72%)
Day's range
$0.34
Day's range
$0.36
$15M$15M$10M$10M$5M$5M$0$0-$5M-$5MEarning20172017201820182019201920202020202120212022202220232023200%200%100%100%0%0%-100%-100%-200%-200%Profit Margin
Profit Margin
Revenue
Earnings

BGLC Income statement / Annual

Last year (2023), BioNexus Gene Lab Corp.'s total revenue was $9.77 M, a decrease of 10.60% from the previous year. In 2023, BioNexus Gene Lab Corp.'s net income was -$2.63 M. See BioNexus Gene Lab Corp.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $9.77 M $10.93 M $13.36 M $11.39 M $126,955.00 $212,328.00 $107,680.00 $0.00
Cost of Revenue $8.44 M $9.67 M $11.17 M $9.67 M $71,067.00 $183,563.00 $28,871.00 $0.00
Gross Profit $1.33 M $1.26 M $2.19 M $1.72 M $55,888.00 $28,765.00 $78,809.00 $0.00
Gross Profit Ratio 0.14 0.12 0.16 0.15 0.44 0.14 0.73 0
Research and Development Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
General & Administrative Expenses $4.41 M $1.73 M $1.20 M $1.33 M $356,641.00 $241,930.00 $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $4.41 M $1.73 M $1.20 M $1.33 M $356,641.00 $241,930.00 $206,715.00 $835.00
Other Expenses -$486,036.00 -$179,283.00 -$66,491.00 -$886,942.00 -$25,048.00 $273,066.00 $0.00 $0.00
Operating Expenses $3.92 M $1.55 M $1.14 M $446,001.00 $331,593.00 -$31,136.00 $206,715.00 $835.00
Cost And Expenses $12.36 M $11.22 M $12.31 M $10.12 M $402,660.00 $152,427.00 $235,586.00 $835.00
Interest Income $0.00 $12,479.00 $12,973.00 $11,313.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $13,929.00 $12,479.00 $12,973.00 $11,313.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $108,423.00 $105,419.00 $108,215.00 $101,603.00 $53,332.00 $40,611.00 $15,031.00 $835.00
EBITDA -$2.49 M -$185,761.00 $1.16 M $1.38 M -$222,373.00 $100,512.00 -$104,383.00 $0.00
EBITDA Ratio -0.25 -0.02 0.09 0.12 -1.75 0.47 -1.05 0
Operating Income Ratio -0.27 -0.03 0.08 0.11 -2.17 0.28 -1.19 0
Total Other Income/Expenses Net -$13,929.00 -$12,479.00 -$12,973.00 -$11,313.00 $0.00 $0.00 $0.00 $5.00
Income Before Tax -$2.61 M -$303,656.00 $1.04 M $1.26 M -$275,705.00 $59,901.00 -$119,414.00 -$835.00
Income Before Tax Ratio -0.27 -0.03 0.08 0.11 -2.17 0.28 -1.11 0
Income Tax Expense $21,526.00 $52,310.00 $291,283.00 $168,411.00 -$29,236.00 $33,447.00 $4,336.00 -$835.00
Net Income -$2.63 M -$355,966.00 $751,571.00 $1.09 M -$246,469.00 $26,454.00 -$123,750.00 -$835.00
Net Income Ratio -0.27 -0.03 0.06 0.1 -1.94 0.12 -1.15 0
EPS -0.17 -0.0247 0.0527 0.13 -0.0342 0.0048 -0.0199 -0.0001
EPS Diluted -0.17 -0.0247 0.0527 0.13 -0.0342 0.0048 -0.0199 -0.0001
Weighted Average Shares Out $15.88 M $14.41 M $14.27 M $8.58 M $7.20 M $5.53 M $6.22 M $6.22 M
Weighted Average Shares Out Diluted $15.88 M $14.41 M $14.27 M $8.58 M $7.20 M $5.53 M $6.22 M $6.22 M
Link